Hydrolysis targeting chimera based on artificial antibody and preparation method and application thereof
By coupling artificial gold antibodies and lysosomal sorting signal motif peptides to the surface of gold nanoparticles, a hydrolysis-targeting chimera is formed, solving the problems of size, linkage, and stability of targeted protein degradation drugs, and achieving efficient targeted binding and cell degradation.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- SHANGHAI UNIV
- Filing Date
- 2026-03-17
- Publication Date
- 2026-07-17
AI Technical Summary
Existing targeted protein degradation drugs suffer from problems such as poor pharmacokinetics due to their large size, difficulty in linking, high development costs, poor stability, and difficulty in controlling the alignment of peptides and nanoparticles.
Artificial gold antibodies and molecules that can activate cellular degradation mechanisms are coupled to the surface of gold nanoparticles to form a hydrolysis-targeting chimera. Targeted degradation is achieved by the artificial gold antibody binding to the target protein and activating lysosomal sorting signal motif-mediated endocytosis.
It improves the affinity and stability of target protein binding, reduces development difficulty, decreases drug size, enhances pharmacokinetic characteristics, and avoids the destruction of binding conformation and uncontrollable orientation.
Smart Images

Figure CN122404558A_ABST
Abstract
Citation Information
Patent Citations
Artificial antibody for targeting EGFR (epidermal growth factor receptor) based on gold nanoparticles and preparation method thereof
CN106699890A